Navigation Links
Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
Date:8/4/2008

SAN FRANCISCO, Aug. 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss second quarter 2008 progress and provide a general business update on Monday, August 11, 2008, at 4:30 p.m. Eastern time. A financial results press release for the second quarter ended June 30, 2008 will be released after markets close on August 11, 2008.

Interested parties may call 877-397-0286 from the U.S. or +1-719-325-4901 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the positive results seen in its Phase 2 trial. For more information, please visit us at http://www.medivation.com.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
2. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Senior Management Promotions
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Research and Markets ... Genomics Market 2014-2018" report to their offering. ... is the study of the genetic material or genomes ... strong basis for the discovery and development of diagnostic ... or health conditions. Genomics is supported by three major ...
(Date:7/31/2014)... Held at the Stanford Cancer Center, ... of the disease and its treatment. Survivors will find ... well as updates on the state-of-the-art with respect to ... for organizing this educational opportunity,” says KCA CEO Bill ... her colleagues have put together a program that balances ...
(Date:7/31/2014)... , July 31, 2014   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... quarter 2014 financial results will be released on Thursday, ... a conference call and live webcast at 4:30 p.m. ...
(Date:7/30/2014)... LA JOLLA, Calif. , July 30, 2014 /PRNewswire/ ... RGLS ), a biopharmaceutical company leading the discovery and ... it will report financial results and highlights for the ... 2014, after the U.S. financial markets close. ... on Wednesday, August 6, 2014, at 5:00 pm Eastern ...
Breaking Biology Technology:Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... 2012   Spherix Incorporated (NASDAQ: SPEX) – ... metabolic syndrome and atherosclerosis, and provider of technical ... and pharmaceutical companies, today reported the successful completion ... drug candidate, SPX-106.  Results demonstrated an ample margin ...
... IndustryWeek magazine today named the Life ... Austin, Texas, one of its Top Ten Plants in North ... win the prestigious award.  IndustryWeek noted the plant,s ... since 2007; 94% error reduction in production documentation process; $4.2 ...
... , Troy, N.Y. Engineering researchers at Rensselaer Polytechnic ... nanomaterials that could lead to highly efficient refrigerators and ... The key ingredients for this innovation are a dash ... At the heart of these solid-state cooling systems ...
Cached Biology Technology:Spherix Announces Successful Completion of Important Toxicology Study of SPX-106 2Spherix Announces Successful Completion of Important Toxicology Study of SPX-106 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 4Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrow's air conditioners 2Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrow's air conditioners 3Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrow's air conditioners 4
(Date:7/31/2014)... CORAL SPRINGS, Florida , July 31, 2014 /PRNewswire/ ... compete to develop unique and innovative smart technologies; companies ... Inc. (NASDAQ: EBAY ), Amazon.com Inc. (NASDAQ: ... FB ), Google Inc. (NASDAQ: GOOG ) ... OTCQB) a biometric authentication company focused on the growing m-commerce ...
(Date:7/30/2014)... The black truffle uses reversible epigenetic processes to regulate ... The ,methylome, - a picture of the genome regulation ... open access journal Genome Biology and illustrates ... elements and ,jumping genes,. The authors say this may ... are controlled. , Black truffles (Tuber melanosporum), also known ...
(Date:7/30/2014)... shortest distance between two points is a straight line, ... been taking the familiar axiom to heart. , ... be intense, with each racing for the chance to ... sperm form cooperative groups that allow them to take ... new study, conducted by Heidi Fisher, a post-doctoral student ...
Breaking Biology News(10 mins):Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6How black truffles deal with the jumpers in their genome 2When cooperation counts 2When cooperation counts 3
... preference for speech through in-utero eavesdropping, or is their ... test, but one that's central to understanding the origins ... a McGill University psychologist believes she's separated out the ... results, says Dr. Athena Vouloumanos, point to a genetic ...
... University of Pennsylvania School of Medicine discovered that a ... internal molecular clock in mammals. What's more, this molecule ... light on circadian rhythm disorders, including bipolar disorder. The ... metabolism, are reported in this week's issue of Science. ...
... Scientists supported by the National Institute of Allergy and ... Health (NIH), have identified a defect in the immune ... that puts them at risk of developing serious complications ... Ph.D., of the National Jewish Medical and Research Center ...
Cached Biology News:Born with a love of speech 2Born with a love of speech 3Clock molecule's sensitivity to lithium sheds light on bipolar disorder 2Defective immune system response to smallpox vaccine detailed in new study 2Defective immune system response to smallpox vaccine detailed in new study 3
... is a direct antibiotic-based selection system for ... colony survival, eliminating the need for costly ... provides close to 100% accuracy in recombinant ... for robot colony picking. This cloning ...
...
The F40 pump maintenance kit is used to service one F40 pump of a BioLogic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: